SOURCE: slp3D

June 14, 2005 07:15 ET

Reminder - OR-Live.com Presents: Minimally Invasive Radioguided Parathyroid (MIRP) Surgery for the Treatment of Parathyroid Tumors

Live Webcast: Tuesday, June 14, 2005, at 4 pm EDT (20:00 UTC) From Tampa General Hospital and Dr. James Norman - World Leaders in Parathyroid Surgery

TAMPA, FL -- (MARKET WIRE) -- June 14, 2005 -- On June 14, 2005, at 4 pm EDT, James Norman, M.D., F.A.C.S., F.A.C.E, Endocrine Surgeon at Tampa General Hospital in Tampa, Florida, will perform live over the internet a minimally invasive radioguided parathyroid (MIRP) surgery. This new procedure is for the treatment of parathyroid tumors. MIRP Parathryoid Surgery has the highest cure rate and is the least invasive of all parathyroid operations.

Tampa General Hospital is recognized as a leader in the treatment of endocrine disorders and parathyroid tumors.

Dr. Norman is one of the world's foremost experts on parathyroid disease and has treated more patients with parathyroid disease than any other doctor in the world. He limits his surgical practice exclusively to parathyroid surgery and performs 6 to 8 parathyroid operations daily at Tampa General Hospital.

A board certified surgeon and a Fellow of the American College of Surgeons; he is also a Fellow of the American College of Endocrinology. Dr. Norman developed minimally invasive parathyroid surgery in the mid 1990s, which has dramatically changed the way parathyroid surgery is performed. This technique uses intraoperative nuclear mapping -- a method that allows virtually all parathyroid operations to be performed through a 1-inch incision. The operation takes less than 16 minutes on average, with over 2,000 consecutive patients going home within 2 hours of the operation. Intraoperative nuclear mapping allows the assessment of the physiologic activity of individual parathyroid glands in real-time, thus negating the need for frozen section in 95% of cases and hormone assays in 100% of cases. These techniques along with Dr. Norman's experience provides for a cure rate of over 99%.

Visit http://www.or-live.com/tgh/1331 now to learn more and view a program preview. A VNR is available at http://www.or-live.com/rams/tag-1331-mkw-q.ram

Contact Information

  • Contact:
    Alex Fraser
    Director of Marketing
    slp3D, Inc
    860-953-2900 x 214